Search company, investor...


Founded Year



Unattributed - III | Alive

Total Raised


Last Raised

$2.4M | 7 yrs ago

About Wicab

Wicab is a Wisconsin-based medical device company dedicated to providing assistive devices for the blind based on sensory substitution technology originally. The company's first produce, the BrainPort V100, is an oral electronic vision aid that provides electro-tactile stimulation to aid profoundly blind patients in orientation, mobility, and object recognition as an adjunctive device to other assistive methods such as the white cane or a guide dog.

Headquarters Location

8313 Greenway Boulevard Suite 100

Middleton, Wisconsin, 53562,

United States


Missing: Wicab's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Wicab's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Wicab

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Wicab is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,915 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Wicab Patents

Wicab has filed 4 patents.

The 3 most popular patent topics include:

  • Endocrine system
  • G protein coupled receptors
  • Neuroscience
patents chart

Application Date

Grant Date


Related Topics




Olfactory receptors, Sensory systems, Neuroscience, Perception, Physiology


Application Date


Grant Date



Related Topics

Olfactory receptors, Sensory systems, Neuroscience, Perception, Physiology



Latest Wicab News

Wicab, Inc. Granted U.S. Patent For Treatment Of Impaired Motor Control Or Function

May 26, 2020

Wicab, Inc. Granted U.S. Patent For Treatment Of Impaired Motor Control Or Function First Patent Issued to the Company in the U.S. Provides Coverage for Treatment of Motor Control or Function Disabilities Using Wicab's BrainPort® Balance Plus Device Author: May 26, 2020 1:00 PM EDT MIDDLETON, Wis., May 26, 2020 /PRNewswire/ -- WICAB, Inc. ("WICAB" or the "Company") today announced that the United States Patent and Trademark Office issued to the Company U.S. Patent No. 10,589,087  related to methods of treating patients with impaired motor control or function. The patent claims encompass methods of providing rehabilitative improvement of motor control or function to a patient using Wicab's BrainPort® Balance Plus device as a biofeedback balance training aid during physical movement or exercise in a rehabilitative therapy program. Examples of rehabilitative improvements encompassed by the claims include improved balance, alleviation of dyskinesias, alleviation of dystonia, alleviation of tremor, alleviation of gait problems, and alleviation of slowness of movement. A variety of different types of patients are encompassed by the claims including patients with bilateral vestibular dysfunction, patients with traumatic brain injury, patients with stroke or cerebellar lesion, and patients with Mal de Debarquement syndrome. "We are pleased to receive this patent based on years of research led by Dr. Paul Bach-y-Rita, a pioneer in the development of tools to treat patients suffering from neurological disorders," said William Conn, the company's Acting CEO. About the BrainPort® Balance Plus The new BrainPort® Balance Plus device was developed for patients suffering from chronic balance disorders. The device provides the user immediate biofeedback regarding their head and body position when performing balance training exercises. This feedback is achieved via gentle electro-tactile impulses from a small array placed on the user's tongue. Therapy with the device has helped many people improve their balance, posture and gait, enhancing their quality of life. The BrainPort® Balance Plus device is licensed by Health Canada and is being sold in Canada. The device is not cleared for sale in the United States. More information is available online at . About Wicab, Inc. Wicab, Inc., located in Middleton, WI, is a privately held medical device company dedicated to providing innovative products for individuals based on sensory substitution technology originally developed by Dr. Paul Bach-y-Rita at the University of Wisconsin-Madison. Wicab, Inc. is an ISO 13485-2016 certified medical device company. Press Contact Related Images brainport-balance-plus-device.jpg BrainPort Balance Plus Device The BrainPort Balance Plus is indicated for use by individuals with vestibular dysfunction for the improvement of balance, gait, posture, and related symptoms. The device provides the user immediate biofeedback regarding their head and body position when performing balance training exercises. View original content to download multimedia: SOURCE Wicab, Inc.

Wicab Frequently Asked Questions (FAQ)

  • When was Wicab founded?

    Wicab was founded in 1998.

  • Where is Wicab's headquarters?

    Wicab's headquarters is located at 8313 Greenway Boulevard, Middleton.

  • What is Wicab's latest funding round?

    Wicab's latest funding round is Unattributed - III.

  • How much did Wicab raise?

    Wicab raised a total of $7.95M.

  • Who are the investors of Wicab?

    Investors of Wicab include University of Wisconsin Endowment, Haiyin Capital and Wisconsin Alumni Research Foundation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.